GlassScriptPhysician profile
Sohni Reddy
NPI 1194107862
$3,563.32
in general payments reported to CMS, 2019-2025
42 companies · $2,532 in 2025
The $2,532 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.74 · 2023: $211 · 2024: $784 · 2025: $2,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,526.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $420.00 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $283.14 | 2024-2025 | |
| Radius Health, INC. | $202.89 | 2024-2025 | Tymlos |
| Amgen INC. | $201.72 | 2024-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.41 | 2024-2025 | Xifaxan |
| Lilly USA, LLC | $177.90 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $169.38 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Ucb, INC. | $163.86 | 2024-2025 | Nayzilam, Briviact, Rystiggo |
| Exact Sciences Corporation | $157.70 | 2024-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $148.24 | 2024-2025 | |
| Pfizer INC. | $143.03 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $124.84 | 2024-2025 | Rexulti |
| Ibsa Pharma INC. | $120.82 | 2024-2025 | Licart, Tirosint, Flector |
| Aimmune Therapeutics, INC. | $108.37 | 2025 | Zenpep |
| Sanofi-Aventis U.S. LLC | $88.55 | 2024-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $76.34 | 2025 | |
| Abbott Laboratories | $64.14 | 2023 | Freestyle Libre 3 |
| Insulet Corporation | $63.42 | 2025 | Omnipod |
| Lundbeck LLC | $57.63 | 2025 | Vyepti, Rexulti |
| Dexcom, INC. | $49.08 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.75 | 2025 | Jardiance |
| Ascendis Pharma Endocrinology INC | $42.51 | 2025 | Yorvipath |
| Glaxosmithkline, LLC. | $37.32 | 2024-2025 | Shingrix, Arexvy |
| Axsome Therapeutics, INC. | $34.40 | 2025 | Symbravo |
| Tandem Diabetes Care, INC. | $28.39 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Astellas Pharma US INC | $28.29 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $27.84 | 2025 | |
| Springworks Therapeutics, INC. | $27.54 | 2025 | Gomekli |
| Ultragenyx Pharmaceutical INC. | $24.60 | 2023 | |
| Biogen, INC. | $23.95 | 2025 | Tysabri, Vumerity |
| Inspire Medical Systems, INC. | $22.54 | 2024 | Inspire |
| Viiv Healthcare Company | $21.71 | 2024 | Apretude |
| Beta Bionics, INC. | $21.24 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Avvisto Therapeutics, LLC | $20.98 | 2025 | Cycloset |
| Kyowa Kirin, INC. | $20.33 | 2025 | |
| Azurity Pharmaceuticals, INC. | $18.95 | 2025 | Azmiro |
| Dynavax Technologies Corporation | $18.22 | 2025 | Heplisav-B |
| Medtronic, INC. | $17.79 | 2023 | Intellis Adaptivestim |
| Recordati_rare_diseases_inc. | $17.05 | 2025 | Isturisa |
| Merck Sharp & Dohme LLC | $15.95 | 2025 | Capvaxive, Gardasil 9 |
| Evoke Pharma, INC. | $15.63 | 2025 | |
| Janssen Pharmaceuticals, INC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohni Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.